Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 1283 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 1424 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 1498 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 1511 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 1693 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 1742 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 1757 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 1759 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 1829 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 1899 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 2298 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 2398 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 2487 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 2680 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 2783 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 2850 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 2908 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 3193 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 3368 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 3672 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 3693 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 4380 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | 8635 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | Peak area normalized | female | Pre-diabetic | Neuropathy | |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | Peak area normalized | male | Pre-diabetic | Neuropathy | |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (M-H)- | Peak area normalized | male | Pre-diabetic | no neuropathy |